Growth Metrics

Biogen (BIIB) Other Non-Current Assets (2016 - 2026)

Biogen has reported Other Non-Current Assets over the past 18 years, most recently at $777.5 million for Q1 2026.

  • For Q1 2026, Other Non-Current Assets rose 39.06% year-over-year to $777.5 million; the TTM value through Mar 2026 reached $777.5 million, up 39.06%, while the annual FY2025 figure was $750.6 million, 33.92% up from the prior year.
  • Other Non-Current Assets for Q1 2026 was $777.5 million at Biogen, up from $750.6 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $1.8 billion in Q1 2022 and troughed at $559.1 million in Q1 2025.
  • A 5-year average of $965.9 million and a median of $750.6 million in 2025 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: crashed 53.21% in 2023 and later surged 39.06% in 2026.
  • Year by year, Other Non-Current Assets stood at $1.5 billion in 2022, then crashed by 51.28% to $745.0 million in 2023, then decreased by 24.77% to $560.5 million in 2024, then skyrocketed by 33.92% to $750.6 million in 2025, then grew by 3.58% to $777.5 million in 2026.
  • Business Quant data shows Other Non-Current Assets for BIIB at $777.5 million in Q1 2026, $750.6 million in Q4 2025, and $729.7 million in Q3 2025.